Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Reproduction

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1577872

Study on the relationship between endometrial thickness on hCG day in the progestin-primed ovarian stimulation protocols and pregnancy outcomes in frozen-thawed embryo transfer cycles

Provisionally accepted
Yutong  WangYutong Wang1,2,3Yajie  ChangYajie Chang1,2,3Shaohong  ZhuangShaohong Zhuang1,2,3Haitao  ZengHaitao Zeng1,2,3Xiaoyan  LiangXiaoyan Liang1,2,3*
  • 1Reproductive Medicine Center, Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
  • 2Guangdong Engineering Technology Research Center of Fertility Preservation, Guangzhou, China
  • 3Biomedical Innovation Center, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

The final, formatted version of the article will be published soon.

Objective To investigate the relationship between endometrial thickness (EMT) on hCG day in the progestin-primed ovarian stimulation (PPOS) protocol and pregnancy outcomes in the following frozen-thawed embryo transfer (FET) cycles, providing new insights into embryo transfer strategies for patients undergoing PPOS protocols. Methods A retrospective study including 1,748 patients underwent PPOS protocols were included. Patients were divided into two groups based on EMT on hCG day: Group A (<8 mm) and Group B (≥8 mm). After 1:1 propensity score matching (Group A: n=701, Group B: n=701), biochemical pregnancy rates, clinical pregnancy rates, and ongoing pregnancy rates were compared. Additionally, pregnancy outcomes under different endometrial preparation protocols were analyzed within each group. Results 1. The biochemical pregnancy rates in Groups A and B were 44.5% and 45.5% (p=0.707), the clinical pregnancy rates were 38.5% and 42.5% (p=0.128), and the ongoing pregnancy rates were 29.1% and 34.2% (p=0.039). For cleavage-stage embryo transfers, Groups A and B showed no significant differences in biochemical pregnancy rates (39.5% vs. 35%, p=0.285), clinical pregnancy rates (35.9% vs. 30.5%, p=0.192), and ongoing pregnancy rates (26.8% vs. 24.4%, p=0.527). For blastocyst transfers, biochemical pregnancy rates (47.8% vs. 51.2%, p=0.307), clinical pregnancy rates (40.2% vs. 49%, p=0.009), and ongoing pregnancy rates (30.6% vs. 39.6%, p=0.005) were significantly higher in Group B; 2. In Group A, the endometrial preparation protocols had no statistically significant effect on pregnancy outcomes, but the natural cycles showed potentially better results (biochemical pregnancy rate: 43.1%, clinical pregnancy rate: 40.0%, ongoing pregnancy rate: 34.1%) than HRT (44.1%, 38.6%, 29.9%) , GnRH-a+HRT (45.1%, 39.3%, 26.3%), and mild stimulation cycles (27.8%, 16.7%, 11.1%). In Group B, patients using GnRH-a+HRT protocols showed higher biochemical pregnancy rates (53.5%, p=0.022), clinical pregnancy rates (48.7%, p=0.096), and ongoing pregnancy rates (40.4%, p=0.032) compared to the natural cycles (38.2%, 33.9%, 25.2%), HRT (42.9%, 40.8%, 33.8%), and mild stimulation protocols (45.5%, 45.5%, 27.3%). Conclusions EMT on the hCG day in PPOS cycles was positively related to pregnancy outcomes of subsequent FET, with EMT ≥8 mm associated with better pregnancy outcomes, especially in patients undergoing blastocyst transfers.

Keywords: Progestin-primed ovarian stimulation, Endometrial thickness, Frozen-thawed embryo transfer, Pregnancy Outcome, Endometrial preparation

Received: 16 Feb 2025; Accepted: 08 Aug 2025.

Copyright: © 2025 Wang, Chang, Zhuang, Zeng and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xiaoyan Liang, Reproductive Medicine Center, Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.